Design Therapeutics financial statements

디자인 테라퓨틱스NASDAQ:DSGN · Nasdaq · Healthcare · sector #17
$11.69-2.34%
2026-10-07 close · prelim

Design Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$62M.

Reported results

Design Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy